AL Amyloidosis: The Effect of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes.

Michael OzgaQiuhong ZhaoDon BensonPatrick ElderNita WilliamsNaresh BummaAshley RoskoMaria ChaudhryAbdullah KhanSrinivas DevarakondaRami KahwashAjay VallakatiCourtney M CampbellSamir V ParikhSalem AlmaaniJason ProsekJordan BittengleKatherine PfundSamantha LoRussoMiriam FreimerElyse RedderYvonne EfeberaNidhi Sharma

Published in: Journal of clinical medicine (2020)

Maintenance therapy post ASCT did not impact PFS or OS when categorized by FISH abnormalities, increasing BMPC, or ≥2 organs involved in AL amyloidosis patients.

Keyphrases

stem cell transplantation
end stage renal disease
high dose
newly diagnosed
chronic kidney disease
prognostic factors
multiple myeloma
cell therapy
bone marrow
peritoneal dialysis
low dose
metabolic syndrome
mesenchymal stem cells
insulin resistance
weight loss